Abstract
Engagement of the B-cell antigen receptor (BCR) or the nerve growth factor receptor (NGFR/TrkA) induces activation of multiple tyrosine kinases, resulting in phosphorylation of numerous intracellular substrates. We show that addition of NGF or anti-IgM antibody leads to the early tyrosine phosphorylation of p95(vav), which is expressed exclusively in hematopoietic cells; NGF, similar to crosslinking the BCR, also results in the rapid activation of Ras. The phosphorylation of Vav and activation of Ras triggered by NGF is mediated through Trk tyrosine kinase, whereas signalling through the BCR uses a different tyrosine kinase. We also show that NGF induces tyrosine phosphorylation of Shc and its association with Grb2. Vav and Ras with the adaptor proteins Shc and Grb2 appear to serve as a link between different receptor-mediated signaling pathways and, in human B cells, may play an important regulatory role in neuroimmune interactions.
Original language | English |
---|---|
Pages (from-to) | 83-89 |
Number of pages | 7 |
Journal | Cellular Immunology |
Volume | 191 |
Issue number | 2 |
DOIs | |
State | Published - 1 Feb 1999 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported in part by NIH Grants AI-29704 and HL-36577 and Grant 93-00274 from the United States–Israel Binational Science Foundation (BSF), Jerusalem, Israel. Dr. Melamed is a recipient of the Janssen Pharmaceutica Research Award in Allergic Rhinitis from the American Academy of Allergy, Asthma and Immunology. The authors thank Drs. John Cambier and David Kaplan for helpful discussions and Diana Nabighian for preparation of the manuscript.
Funding
This work was supported in part by NIH Grants AI-29704 and HL-36577 and Grant 93-00274 from the United States–Israel Binational Science Foundation (BSF), Jerusalem, Israel. Dr. Melamed is a recipient of the Janssen Pharmaceutica Research Award in Allergic Rhinitis from the American Academy of Allergy, Asthma and Immunology. The authors thank Drs. John Cambier and David Kaplan for helpful discussions and Diana Nabighian for preparation of the manuscript.
Funders | Funder number |
---|---|
National Institutes of Health | 93-00274, HL-36577 |
National Institute of Allergy and Infectious Diseases | R01AI029704 |
United States-Israel Binational Science Foundation |